@article{9fc55883108b445bb025c170872780b7,
title = "Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia",
abstract = "A GGGGCC repeat expansion in C9orf72 leads to frontotemporal dementia and/or amyotrophic lateral sclerosis. Diverse pathological features have been identified, and their disease relevance remains much debated. Here, we describe two illuminating patients with frontotemporal dementia due to the C9orf72 repeat expansion. Case 1 was a 65-year-old female with behavioural variant frontotemporal dementia accompanied by focal degeneration in subgenual anterior cingulate cortex, amygdala, and medial pulvinar thalamus. At autopsy, widespread RNA foci and dipeptide repeat protein inclusions were observed, but TDP-43 pathology was nearly absent, even in degenerating brain regions. Case 2 was a 74-year-old female with atypical frontotemporal dementia-motor neuron disease who underwent temporal lobe resection for epilepsy 5 years prior to her first frontotemporal dementia symptoms. Archival surgical resection tissue contained RNA foci, dipeptide repeat protein inclusions, and loss of nuclear TDP-43 but no TDP-43 inclusions despite florid TDP-43 inclusions at autopsy 8 years after first symptoms. These findings suggest that C9orf72-specific phenomena may impact brain structure and function and emerge before first symptoms and TDP-43 aggregation.",
keywords = "Frontotemporal dementia, Protein aggregation, TDP-43",
author = "Vatsavayai, {Sarat C.} and Yoon, {Soo Jin} and Gardner, {Raquel C.} and Gendron, {Tania F.} and Vargas, {Jose Norberto S.} and Andrew Trujillo and Mochtar Pribadi and Phillips, {Joanna J.} and Gaus, {Stephanie E.} and Hixson, {John D.} and Garcia, {Paul A.} and Rabinovici, {Gil D.} and Giovanni Coppola and Geschwind, {Daniel H.} and Leonard Petrucelli and Miller, {Bruce L.} and Seeley, {William W.}",
note = "Funding Information: We thank participants and their families for their invaluable contributions to neurodegeneration research. This work was supported by the NIH/National Institute of Aging (P50 AG023501 to B.L.M. and W.W.S., P01 AG019724 to B.L.M. and W.W.S., P50AG016574 to L.P., and P30AG044281 to R.C.G.) and Consortium for Frontotemporal Dementia Research. This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke [K23NS095755 (R.C.G.), R21NS089979 (T.F.G.), R21NS084528 (L.P.), R01NS088689 (L.P.), R01NS063964 (L.P.); R01NS077402 (L.P.); P01NS084974 (L.P.)], National Institute of Environmental Health Services [R01ES20395 (L.P.)], and the ALS Association (T.F.G., L.P.). Antibodies generated by L.P. and T.F.G. used in this study have been licensed to commercial entities. Publisher Copyright: {\textcopyright} The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.",
year = "2016",
month = dec,
doi = "10.1093/brain/aww250",
language = "English (US)",
volume = "139",
pages = "3202--3216",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "12",
}